Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Pilalis

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|May 6, 2022
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancerAitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Plos One|June 4, 2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic ProfilingSofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, et al.
Frontiers in Pharmacology|October 24, 2022
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpressionVerona Buocikova, Silvia Tyciakova, Eleftherios Pilalis, et al.
Cancers|December 8, 2020
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine PerspectivesVerona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer modelsVerona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, et al.
EMBO Molecular Medicine|May 2, 2019
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammationMarion Maurel, Joanna Obacz, Tony Avril, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|May 6, 2022
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancerAitor Almanza, Katarzyna Mnich, Arnaud Blomme, et al.
Plos One|June 4, 2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic ProfilingSofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, et al.
Frontiers in Pharmacology|October 24, 2022
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpressionVerona Buocikova, Silvia Tyciakova, Eleftherios Pilalis, et al.
Cancers|December 8, 2020
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine PerspectivesVerona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer modelsVerona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, et al.
EMBO Molecular Medicine|May 2, 2019
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammationMarion Maurel, Joanna Obacz, Tony Avril, et al.
Pageof 3